Page History
...
Committee Member | Present | Absent |
---|---|---|
X | ||
X | ||
X | ||
X | ||
X | ||
Debbie Knapp | X | |
Toby Hecht | X | |
X |
Goals
- Discuss updates to ICDC and define emerging strategies and priorities
...
Item | Who | Talking Points |
---|---|---|
Discussion of potential submission of FidoCure and Vidium Animal Health data |
| |
DGAB Updates | Recently Approved
ICDC Studies in Active Submission
| |
BPSC Updates |
| |
Upcoming Steering Committee Meeting |
| |
Next Software Release |
|
Minutes (Not Verbatim)
AL - Jerry Post agreed that it is an exciting time for canine oncology. He thinks it would be a good idea for us to connect more. He expressed some concerns with integrating their data with our committee. They have novel data that would be interesting for the ICDC. Vidium has a publication out and may be more willing to share data.
TH - We should schedule a formal session with both groups to reconnect.
TH - Debbie has been in touch and has a paper that has been accepted that actually uses ICDC data.
Previous ICDC Use Cases from Steering Committee
...
8. Develop biomarkers of response and resistance in humans by analyzing the responses and genomic signatures in dogs.
Previous Meeting Minutes (Not Verbatim)
TH - Look at drug responses and the tumor itself to determine if there is a biomarker based on genomic expression. In the Intro of the BPSC paper, we could give examples of things that can be done based upon existing drug trial studies.
...
.
...
DK - Pre and post biopsies were attempted in Vemurafinib trial
AL - Until we have DBs to refer to and a more stable reference genome it is difficult to make progress.
Action items
- Debbie to write invitation for Jaime Modiano
- Revisit new steering committee members in September
- Debbie Knapp to send an email to FidoCure and Vidium to see if these groups are willing to sit down and meet with us.